The challenges and impact of microvascular injury in ST-elevation myocardial infarction

Expert Review of Cardiovascular Therapy
Sebastian Johannes ReinstadlerIngo Eitel

Abstract

Despite successful restoration of epicardial coronary blood flow, a significant proportion of patients with ST-elevation myocardial infarction suffer from an impairment of the microvascular perfusion - a phenomenon termed no-reflow or microvascular injury (MVI). The underlying pathophysiology is complex and likely multifactorial. It is well established that MVI is associated with worse clinical outcome. Although MVI can be detected during coronary intervention and the post-infarction period, its prevention and treatment strategies remain a major challenge since most results of clinical studies have been disappointing so far. This review provides an overview on the main pathophysiological mechanisms of MVI and its diagnostic approaches. Moreover, it will discuss its clinical consequences and current strategies of prevention and treatment.

References

Jan 1, 1990·Methods in Enzymology·B Halliwell, J M Gutteridge
Dec 1, 1974·The Journal of Clinical Investigation·R A KlonerR B Jennings
Jan 1, 1974·The American Journal of Cardiology·G F BresnahanB E Sobel
Apr 1, 1995·The Biochemical Journal·E J Griffiths, A P Halestrap
Jun 23, 2001·The New England Journal of Medicine·G MontalescotUNKNOWN ADMIRAL Investigators. Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long-Te
Nov 3, 2001·Journal of the American College of Cardiology·J A de Lemos, E Braunwald
Aug 16, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Thorsten Reffelmann, Robert A Kloner
Nov 28, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Gerald S WernerHans R Figulla
Jun 25, 2003·Circulation·William F FearonAlan C Yeung
Aug 23, 2003·Circulation Research·James N WeissPeipei Ping
Aug 9, 2005·American Heart Journal·Ugo LimbrunoRaffaele De Caterina
Dec 13, 2005·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Jean-Philippe Collet, Gilles Montalescot
Oct 9, 2007·The American Journal of Cardiology·Cristina BassoSabino Iliceto
Nov 7, 2007·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Martin G StoelFelix Zijlstra
Feb 2, 2008·Journal of the American College of Cardiology·William F FearonAlan C Yeung
Feb 8, 2008·The New England Journal of Medicine·Tone SvilaasFelix Zijlstra
Aug 19, 2008·Lancet·Arnoud W J Van't HofUNKNOWN Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group

❮ Previous
Next ❯

Citations

Jun 7, 2019·Nature Reviews. Disease Primers·Birgit VogelRoxana Mehran
Apr 11, 2020·Journal of Clinical Medicine·Martin ReindlSebastian Johannes Reinstadler
Aug 31, 2018·European Heart Journal Cardiovascular Imaging·Sebastian J ReinstadlerIngo Eitel
Apr 25, 2020·JACC. Cardiovascular Interventions·Sebastian Johannes Reinstadler, Bernhard Metzler
Feb 7, 2021·Open Heart·Christina TillerSebastian Johannes Reinstadler
Mar 9, 2021·Frontiers in Immunology·Ahmed SheriffBirgit Vogt
Jun 21, 2021·International Journal of Cardiology·Magdalena HolzknechtSebastian Johannes Reinstadler
Dec 2, 2021·European Heart Journal. Acute Cardiovascular Care·Christina TillerSebastian J Reinstadler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.